CD14 and COVID-19: Of interest, a decrease in CD14+CD16- classical monocytes was detected in COVID-19 patients with respect to the other two groups, but no changes were noticed in the levels of CD14+CD16+ intermediate and CD14dimCD16+ non-classical monocytes between COVID-19 patients and healthy blood donors (Figure S3).